Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002513096 | SCV003440061 | pathogenic | Supravalvar aortic stenosis | 2022-07-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro720Glnfs*29) in the ELN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ELN are known to be pathogenic (PMID: 11175284). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant is also known as 2039delC. This premature translational stop signal has been observed in individual(s) with autosomal dominant cutis laxa (PMID: 9873040, 16085695). |
OMIM | RCV000018212 | SCV000038491 | pathogenic | Cutis laxa, autosomal dominant 1 | 1995-03-01 | no assertion criteria provided | literature only |